DanCann Pharma A/S publishes Q2-2022 report
COPENHAGEN, Denmark, 31 August 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that the Company has published its report for the second quarter of 2022. The Q2-2022 report is available as an attached document to this press release and at www.dancann.com.Group key figures Q2-2022: KDKK 01/01/22 01/01/21 01/04/22 01/04/21 01/01/21 30/06/22 30/06/21 30/06/22 30/06/21 31/12/21Net sales 2,037 0 771 0 874